Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Ovlašten
- Spectinomycin sulfate
- Lincomycin hydrochloride
Identifikacija proizvoda
Naziv VMP-a:
LINCO-SPECTIN 100 (33,3+66,7)g/150g ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Ciljne vrste životinja:
Način primjene:
-
Kroz usta
Pojedinosti o proizvodu
Farmaceutski oblik:
-
Prašak za uporabu u vodi za piće
Withdrawal period by route of administration:
-
Kroz usta
- Poultry
-
Meat and offal5day5 days; Animals must not be slaughtered for human consumption during treatment.
-
Eggsno withdrawal periodNot authorised for use in birds producing eggs for human consumption, including replacement chicks which are intended to produce eggs for human consumption
-
- Pig
-
Meat and offalno withdrawal period0 days; Animals must not be slaughtered for human consumption during treatment.
-
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QJ01FF52
Status odobrenja:
-
Važeće
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Nositelj odobrenja za stavljanje u promet:
- Zoetis Hellas S.A.
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- Zoetis Belgium
Odgovorno tijelo:
- National Organization For Medicines
Broj autorizacije:
- 45257/26-8-2004/K-0015801
Datum promjene statusa odobrenja:
Broj postupka:
- BE/V/0029/001
Dotična država članica:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: